Sherwood IV Home Therapy is categorized under Medical Labs in Demorest, GA and active since 1995.
Sherwood IV Home Therapy was established in 1995, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 6216100 by the NAICS.
If you are seeking more information, feel free to contact Charles Sherwood, Executive Director at the company’s single location by writing to 415 Fisk Avenue, Demorest, Georgia GA 30535 or by phoning (706) 776-9127. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Sherwood IV Home Therapy |
Contact Person: | Charles Sherwood, Executive Director |
Address: | 415 Fisk Avenue, Demorest, Georgia 30535 |
Phone Number: | (706) 776-9127 |
Website Address: | sherwoodclinical.com |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 1995 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Medical Labs |
SIC Code: | 8071 |
NAICS Code: | 6216100 |
Share This Business: |
Sherwood IV Home Therapy was started in 1995 to provide professional Medical Labs under the SIC code 8071 and NAICS code 6216100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Charles Sherwood, Executive Director for inquiries that concern Sherwood IV Home Therapy by calling the company number (706) 776-9127, as your correspondence is most welcome. Additionally, the physical location of the single location of Sherwood IV Home Therapy can be found at the coordinates 34.55832,-83.54811 as well as the street address 415 Fisk Avenue in Demorest, Georgia 30535.
For its online presence, you may visit Sherwood IV Home Therapy’s website at sherwoodclinical.com and engage with its social media outlets through on Twitter and on Facebook.